Literature DB >> 26108462

microRNA Biomarker Discovery and High-Throughput DNA Sequencing Are Possible Using Long-term Archived Serum Samples.

Trine B Rounge1, Marianne Lauritzen2, Hilde Langseth2, Espen Enerly2, Robert Lyle3, Randi E Gislefoss2.   

Abstract

BACKGROUND: The impacts of long-term storage and varying preanalytical factors on the quality and quantity of DNA and miRNA from archived serum have not been fully assessed. Preanalytical and analytical variations and degradation may introduce bias in representation of DNA and miRNA and may result in loss or corruption of quantitative data.
METHODS: We have evaluated DNA and miRNA quantity, quality, and variability in samples stored up to 40 years using one of the oldest prospective serum collections in the world, the Janus Serumbank, a biorepository dedicated to cancer research.
RESULTS: miRNAs are present and stable in archived serum samples frozen at -25°C for at least 40 years. Long-time storage did not reduce miRNA yields; however, varying preanalytical conditions had a significant effect and should be taken into consideration during project design. Of note, 500 μL serum yielded sufficient miRNA for qPCR and small RNA sequencing and on average 650 unique miRNAs were detected in samples from presumably healthy donors. Of note, 500 μL serum yielded sufficient DNA for whole-genome sequencing and subsequent SNP calling, giving a uniform representation of the genomes.
CONCLUSIONS: DNA and miRNA are stable during long-term storage, making large prospectively collected serum repositories an invaluable source for miRNA and DNA biomarker discovery. IMPACT: Large-scale biomarker studies with long follow-up time are possible utilizing biorepositories with archived serum and state-of-the-art technology. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26108462     DOI: 10.1158/1055-9965.EPI-15-0289

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  16 in total

1.  Circulating MicroRNAs in Relation to Esophageal Adenocarcinoma Diagnosis and Survival.

Authors:  Jessica L Petrick; Ruth M Pfeiffer; Linda M Liao; Christian C Abnet; Xiaolin Wu; Marilie D Gammon; Thomas L Vaughan; Michael B Cook
Journal:  Dig Dis Sci       Date:  2021-01-06       Impact factor: 3.199

2.  Sources to variability in circulating human miRNA signatures.

Authors:  Andreas Keller; Trine Rounge; Christina Backes; Nicole Ludwig; Randi Gislefoss; Petra Leidinger; Hilde Langseth; Eckart Meese
Journal:  RNA Biol       Date:  2017-09-13       Impact factor: 4.652

Review 3.  Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory.

Authors:  José Luis García-Giménez; Marta Seco-Cervera; Trygve O Tollefsbol; Carlos Romá-Mateo; Lorena Peiró-Chova; Pablo Lapunzina; Federico V Pallardó
Journal:  Crit Rev Clin Lab Sci       Date:  2017-12-11       Impact factor: 6.250

4.  Use of Serum MicroRNAs as Biomarker for Hepatobiliary Diseases in Dogs.

Authors:  K Dirksen; T Verzijl; G C Grinwis; R P Favier; L C Penning; I A Burgener; L J van der Laan; H Fieten; B Spee
Journal:  J Vet Intern Med       Date:  2016-11-11       Impact factor: 3.333

5.  Association of Serum MiR-142-3p and MiR-101-3p Levels with Acute Cellular Rejection after Heart Transplantation.

Authors:  Ihdina Sukma Dewi; Zsuzsanna Hollander; Karen K Lam; Janet-Wilson McManus; Scott J Tebbutt; Raymond T Ng; Paul A Keown; Robert W McMaster; Bruce M McManus; Olof Gidlöf; Jenny Öhman
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

6.  Genome-wide analysis suggests a differential microRNA signature associated with normal and diabetic human corneal limbus.

Authors:  Mangesh Kulkarni; Aleksandra Leszczynska; Gabbie Wei; Michael A Winkler; Jie Tang; Vincent A Funari; Nan Deng; Zhenqiu Liu; Vasu Punj; Sophie X Deng; Alexander V Ljubimov; Mehrnoosh Saghizadeh
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

7.  MicroRNA-related polymorphisms in apoptosis pathway genes are predictive of clinical outcome in patients with limited disease small cell lung cancer.

Authors:  Wei Jiang; Nan Bi; Wen-Jue Zhang; Li-Hong Wu; Li-Pin Liu; Yu Men; Jing-Bo Wang; Jun Liang; Zhou-Guang Hui; Zong-Mei Zhou; Lu-Hua Wang
Journal:  Oncotarget       Date:  2016-04-19

8.  MicroRNA-Related Polymorphisms in PI3K/Akt/mTOR Pathway Genes Are Predictive of Limited-Disease Small Cell Lung Cancer Treatment Outcomes.

Authors:  Wei Jiang; Wenjue Zhang; Lihong Wu; Lipin Liu; Yu Men; Jingbo Wang; Jun Liang; Zhouguang Hui; Zongmei Zhou; Nan Bi; Luhua Wang
Journal:  Biomed Res Int       Date:  2017-02-09       Impact factor: 3.411

9.  A comprehensive profile of circulating RNAs in human serum.

Authors:  Sinan Uğur Umu; Hilde Langseth; Cecilie Bucher-Johannessen; Bastian Fromm; Andreas Keller; Eckart Meese; Marianne Lauritzen; Magnus Leithaug; Robert Lyle; Trine B Rounge
Journal:  RNA Biol       Date:  2017-12-08       Impact factor: 4.652

10.  Identification of extracellular miRNA in archived serum samples by next-generation sequencing from RNA extracted using multiple methods.

Authors:  Aarti Gautam; Raina Kumar; George Dimitrov; Allison Hoke; Rasha Hammamieh; Marti Jett
Journal:  Mol Biol Rep       Date:  2016-08-10       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.